Systemic Chemokine Levels with “Gut-Specific” Vedolizumab in Patients with Inflammatory Bowel Disease—A Pilot Study

Author: Zwicker Stephanie   Lira-Junior Ronaldo   Höög Charlotte   Almer Sven   Boström Elisabeth A.  

Publisher: MDPI

E-ISSN: 1422-0067|18|8|1827-1827

ISSN: 1422-0067

Source: International Journal of Molecular Sciences, Vol.18, Iss.8, 2017-08, pp. : 1827-1827

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content